Form 4: Shattuck Labs Executive Stephen Stout Executes Stock Options and Sells Shares
SEC Form 4 Filing
Stephen Stout, General Counsel, Corporate Secretary, and Chief Ethics and Compliance Officer of Shattuck Labs, exercised stock options and sold shares of common stock on March 6, 2024, according to a Form 4 filing with the SEC.
Summary
- On March 6, 2024, Stephen Stout, an executive at Shattuck Labs, exercised stock options to acquire shares of common stock.
- He then sold a portion of these shares on the same day at a price of $10.53 per share.
- The transactions were executed under a pre-arranged Rule 10b5-1 trading plan adopted on May 23, 2023.
- Following these transactions, Stout directly owns 74,437 shares of Shattuck Labs common stock.
- He also holds options to purchase additional shares.
Sentiment
Score: 5
Explanation: The sentiment is neutral as this is a standard Form 4 filing reporting insider transactions. The transactions themselves don't necessarily indicate a positive or negative outlook for the company.
Industry Context
Form 4 filings are a routine part of the regulatory landscape for publicly traded companies, providing transparency into the transactions of company insiders. These filings are closely watched by investors seeking insights into management's perspective on the company's stock.
Comparison to Industry Standards
- Insider transactions are common in publicly traded companies, and the reporting requirements are standardized by the SEC.
- The use of Rule 10b5-1 trading plans is a typical practice to allow insiders to sell shares without being accused of trading on non-public information.
- Comparable companies in the biotechnology sector also have executives who routinely exercise stock options and sell shares, as part of their compensation and financial planning.
Stakeholder Impact
- The transactions may have a minor impact on shareholders as they involve the sale of shares by an executive.
- However, the existence of a pre-arranged trading plan mitigates concerns about insider information being used for personal gain.
Key Dates
| Date | Description |
|---|---|
| May 23, 2023 | Date the Reporting Person adopted a Rule 10b5-1 trading plan |
| September 8, 2022 | Date of grant for stock options that vest over time |
| January 25, 2023 | Date of grant for stock options that vest over time |
| March 6, 2024 | Date of the reported transactions (exercise of options and sale of shares) |
| March 8, 2024 | Date of signature on the Form 4 filing |
| September 8, 2032 | Expiration date of some stock options |
| January 25, 2033 | Expiration date of some stock options |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.